American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
2007/03/01 by D. Saslow, Debbie Saslow, C. Boetes +27 · 2,653 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #Breast Lesions and Carcinomas #Breast MRI #Breast cancer #Breast cancer screening #Breast imaging #Cancer #Family history #Guideline #Gynecology #Internal medicine #MRI in cancer diagnosis #Magnetic resonance imaging #Mammography #Medicine #Obstetrics #Pathology #Radiology
paper · pdf · doi:10.3322/canjclin.57.2.75
published in CA A Cancer Journal for Clinicians 57(2), 75-89 (Wiley)
openalex publication_date 2007/03/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04
Abstract
New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available since the American Cancer Society (ACS) last issued guidelines for the early detection of breast cancer in 2003. A guideline panel has reviewed this evidence and developed new recommendations for women at different defined levels of risk. Screening MRI is recommended for women with an approximately 20-25% or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease. There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography. Diagnostic uses of MRI were not considered to be within the scope of this review.
Cited by
- Childhood and adolescent cancer statistics, 2014
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study
- Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial
- Performance of Dual-Energy Contrast-enhanced Digital Mammography for Screening Women at Increased Risk of Breast Cancer
- Breast Cancer Screening for Women at Average Risk
- Validation of Fully-Automated Deep Learning-Based Fibroglandular Tissue Segmentation for Efficient and Reliable Quantitation of Background Parenchymal Enhancement in Breast MRI
- Mutational spectrum in a worldwide study of 29,700 families withBRCA1orBRCA2mutations
- Clinical applications of deep learning in breast MRI
- Dense Temporal Contrast Synthesis via Conditioned Latent Transport
- Artificial Intelligence for Breast Cancer Risk Assessment
- Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women
- Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer
- A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer
- Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality
- Genetics for the General Internist
- Risk Models for Breast Cancer and Their Validation
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. [europepmc]
- Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. [europepmc]
- Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. [europepmc]
- Breast cancer before age 40 years. [europepmc]
- Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts. [europepmc]
- High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. [europepmc]
- Screening for breast cancer: an update for the U.S. Preventive Services Task Force. [europepmc]
- Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. [europepmc]
- Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. [europepmc]
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. [europepmc]
- Atypical hyperplasia of the breast--risk assessment and management options. [europepmc]
- Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. [europepmc]
- Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. [europepmc]
- Breast MRI: EUSOBI recommendations for women's information. [europepmc]
- Effects of age on the detection and management of breast cancer. [europepmc]
- Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. [europepmc]
- Counselling framework for moderate-penetrance cancer-susceptibility mutations. [europepmc]
- Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. [europepmc]
- Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review. [europepmc]
- Hodgkin lymphoma: A review and update on recent progress. [europepmc]
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations. [europepmc]
- Contrast-enhanced MRI for breast cancer screening. [europepmc]
- Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening. [europepmc]
- Contrast-enhanced Mammography: State of the Art. [europepmc]
- Modern Diagnostic Imaging Technique Applications and Risk Factors in the Medical Field: A Review. [europepmc]
Related